The direct VEGFR-1-mediated pro-angiogenic activity is usually weak, but the receptor appears to trigger a pathway in cancer cells that induces epithelial–mesenchymal transition, the critical process for acquiring invasive potential and promoting cancer-cell metastasis in vivo [29]. This evidence concerns the gene FLT1 and cancer.